首页> 外文期刊>Clinical advances in hematology & oncology: H&O >Novel treatments in acute lymphocytic leukemia
【24h】

Novel treatments in acute lymphocytic leukemia

机译:急性淋巴细胞白血病的新疗法

获取原文
获取原文并翻译 | 示例
           

摘要

H&O What is acute lymphocytic leukemia (ALL)? AS ALL is a malignancy that originates in hematopoietic cells in the bone marrow. An estimated 6020 new cases will be diagnosed in the United States this year: 3140 in male patients and 2880 in female patients. ALL is the most common cancer in children. Studies have suggested that risk factors for childhood ALL include exposure to chemicals, such as those found in pesticides and household paint. There is an increased incidence of ALL among Hispanics, although the reason is unknown.
机译:H&O什么是急性淋巴细胞白血病(ALL)? AS ALL是一种恶性肿瘤,起源于骨髓中的造血细胞。据估计,今年美国将诊断出6020例新病例:男性患者3140例,女性患者2880例。 ALL是儿童中最常见的癌症。研究表明,儿童期ALL的危险因素包括接触化学物质,例如农药和家用油漆中的化学物质。西班牙裔美国人中ALL的发病率有所增加,尽管原因尚不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号